Arcturus Therapeutics
public company
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA (siRNA), messenger RNA (mRNA), gene editing RNA, DNA, antisense oligonucleotides, and microRNA.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
—
not enough monitored evidence
1 active sensor·1 observation·0 historical changes·0 structured events·historical coverage 83 %·observed since 2026-09-13
Compare Arcturus Therapeutics with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies